Work

Risks of Bariatric Surgery Among Patients With End-stage Renal Disease

Year: 2019

Type: article

Abstract: With End-stage Renal DiseasePretransplant morbid obesity among patients with end-stage renal disease (ESRD) is a significant predictor of delayed access to transplant and inferior posttransplant patient and kidney allograft outcomes.[1][2][3] Despite this, policies directly addressing pretransplant weight management do not exist.While the association between bariatric surgery and longterm weight loss and comorbidity improvement among obese patients with ESRD is well established, surgery is underused in this population owing to perceptions of unacceptable increased perioperative risk.4,5 Perioperative risks of bariatric surgery among obese patients with ESRD are poorly characterized, with limited studies that may not detect rare events.6 In this context, we performed an analysis of perioperative safety of bariatric surgery in obese patients with ESRD using a national registry capturing greater than 95% of bariatric operations.

Source: JAMA Surgery

DOI: 10.1001/jamasurg.2019.2824

Authors: John R. Montgomery, Seth A. Waits, Justin B. Dimick, Dana A. Telem

Institution: University of Michigan

Language: English

Topic: Bariatric Surgery and Outcomes

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, Agency for Healthcare Research and Quality, National Institute of Diabetes and Digestive and Kidney Diseases